Tag: Initial Public Offering (IPO)
McKesson moves MMS closer to IPO
May 15, 2026Liz Beaulieu, Editor
IRVING, Texas – McKesson’s Medical-Surgical Solutions (MMS) segment is now operationally and legally separate, and with new financing and a new minority ownership, it is closer to becoming financially independent, says CFO Britt Vitalone.
In early April, the company announced:
A $1 billion revolving credit facility and the issuance of $1 billion in Term Loan A facilities.
The sale of a 13% minority interest to funds managed by Apollo in a deal that values the segment at $13...
McKesson sells stake in Medical-Surgical Solutions
April 29, 2026HME News Staff
IRVING, Texas – McKesson has taken another step toward separating its Medical-Surgical Solutions (MMS) business by selling a minority interest to funds managed by Apollo.
Apollo Funds will invest $1.25 billion in convertible preferred equity of MMS to acquire an approximately 13% minority interest, valuing the business at approximately $13 billion.
“This transaction marks a key milestone in McKesson’s planned separation of MMS,” said Brian Tyler, CEO of McKesson. “We...
Medtronic’s MiniMed joins Nasdaq
March 17, 2026HME News Staff
GALWAY, Ireland, and NORTHRIDGE, Calif. – MiniMed Group, a subsidiary of Medtronic, has begun trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO). "Today marks an exciting milestone for both MiniMed and Medtronic,” said Geoff Martha, Medtronic chairman and CEO. “Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest...
Medline closes IPO, trades at $42.78
December 29, 2025HME News Staff
NORTHFIELD, Ill. - Medline announced Dec. 18 that it closed its upsized initial public offering (IPO) of 248,439,654 shares of its Class A common stock at a public offering price of $29.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 32,405,172 shares of Class A common stock. Medline intends to use the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares to repay outstanding indebtedness...
Medtronic starts IPO process for MiniMed
December 23, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced that its diabetes business, which will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent split-off. MiniMed intends...
Medline to start trading at $29
December 18, 2025HME News Staff
NORTHFIELD, Ill. – Medline Inc. on Dec. 17 was expected to begin trading shares on the Nasdaq Global Select Market under the symbol “MDLN” at an initial public offering of $29 per share. The upsized IPO is for 216,034,482 shares of its Class A common stock; Medline has granted the underwriters a 30-day option to purchase up to an additional 32,405,172 shares of Class A common stock. The company plans to use the proceeds (net of underwriting...
In brief: Final rule delay, Medline IPO, HME Appreciation Week, Philips earnings
November 5, 2025HME News Staff
WASHINGTON – A final rule with further details about CMS’s next round of the competitive bidding program (CBP) was not released last week, giving industry stakeholders more time to continue advocacy efforts, AAHomecare says.
The 2026 DMEPOS/Home Health Final Rule final rule was expected to be released on Oct. 31.
“Whether that delay is tied to the HME community’s all-out advocacy efforts on CBP provisions...
Medline officially files for IPO
November 3, 2025HME News Staff
NORTHFIELD, Ill. - Medline has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed public offering of its common stock.
The number of shares to be offered and the price range and other terms for the offering have not yet been determined. If the offering is completed, Medline intends to list its stock on the Nasdaq Global Select Market under the symbol “MDLN.” Goldman Sachs & Co. LLC, Morgan Stanley,...
Coming soon? Medline eyes $5B IPO, according to reports
September 30, 2025HME News Staff
NORTHFIELD, Ill. - Medline may soon be ready to pull the trigger on an initial public offering (IPO), according to Bloomberg and other news outlets. The company may file for an IPO as early as late October in a bid to raise $5 billion, potentially valuing it at $50 billion, they report. Earlier this year, Medline confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed IPO of its common stock. In 2021, the company announced...
Beta Bionics announces IPO pricing
January 30, 2025HME News Staff
IRVINE, Calif. – Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share. The gross proceeds to Beta Bionics from the offering, before deducting underwriting discounts and commissions and offering expenses are expected to be $204 million. In addition, the underwriters have a 30-day option to purchase up to an additional 1.8 million shares of common stock at the public offering price, less underwriting...